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ABSTRACT 
BACKGROUND: 
The posterior maxillary segment frequently has insufficient bone mass to 
support dental implants. Sinus floor grafting has been proposed as a viable 
treatment option in such situations. The purpose of the present study is to present 
data on the clinical & radiological outcomes and post-operative morbidity of sinus 
floor elevation procedures performed using the “Sinu-liftTM system” utilizing 
Cersorb®M and PRP prior to implant placement.   
MATERIALS & METHODS: 
Ten systemically healthy patients (6 males and 4 females) within the age 
group of 25-55 years requiring maxillary sinus augmentation for implant 
placement were selected for the study. Pre-operative diagnostic evaluation was 
done using OPG and Computerized tomography scans and bone parameters were 
measured (Bone Height, Bone Volume & Bone Density). Sinus lift procedure 
under local anaesthesia was done using the “sinu-liftTM system” by a transcrestal 
approach and bone augmentation was done using Cerasorb®M and PRP mix. The 
study was  evaluated upto a 6 months period with bone related parameters being 
assessed at base line,1st month,2nd month, 3rd month and 6th month using OPG, 
while CT scans were taken at base line and 6th month and the results were 
analyzed. Statistical analysis was done using “Wilcoxson Signed Rank Sum test”. 
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RESULTS: 
Clinically, no complications were observed during or after the surgical 
procedure. All patients healed uneventfully, and no signs and symptoms of 
maxillary sinus related  complications were observed during the six months period 
following surgery.  
There was a significant increase in the bone parameters at the “desired 
grafted region”. The mean gain in bone height as observed in OPG was 
11.50mm±1.68 from 7.05mm±1.09. Similarly, CT Scan had revealed increased 
measurements from 5.80mm±0.98 to 10.20mm ±1.68 at the 6th month evaluation. 
This was statistically significant. 
 The mean bone volume attained in G.B region was higher 
98.90mm3±54.08 than the N.B region 60.32 mm3±14.39. The mean bone density 
of G.B region recorded an higher density of 537.59HU±148.97 when compared to 
the N.B region 378.02HU±90.27  after six months in CT Scan evaluation.  
CONCLUSION: 
Within the limits of this study, it can be  concluded  that β-Tricalcium 
phosphate in combination with PRP can be successfully used for  augmentation of 
maxillary sinus in atrophic maxilla prior to implant placement. The “Sinu-liftTM 
system” with a controlled working action resulted in high procedural success and 
because it is minimally invasive, this procedure may be an alternative to the 
currently used surgical methods. However, further controlled clinical trials are 
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needed to evaluate the effectiveness and safety of this technique compared to 
other sinus floor elevation procedures. 
KEYWORDS: 
Bone Regeneration, Maxillary Sinus Augmentation, β-TCP, PRP, Sinu-
liftTM system 
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INTRODUCTION 
 
The predictability of Osseointegrated oral implants in the treatment of both 
total or partial edentulism with sufficient bone quantity and quality has been well 
documented.1,3,76A minimum of 10 mm of vertical bone height is usually required 
for predictable implant success.89,33 
However, the placement of dental implants in the atrophic posterior 
maxilla is challenging in implant surgery6,7,118   which has been related to bone 
quality and quantity.12,18,16,136,76  This is due to the  combined resorption of the 
alveolar ridge in the vertical and horizontal direction and also resorption due to 
increased pneumatization of the maxillary sinus22and decrease in the quality and 
quantity of bone which limits the implant placement. Moreover, bone quality in 
this region tends to be the least dense in the oral  cavity76,136typically Type III and 
IV with the highest percentage of type IV bone.136 The residual ridge height as 
measured in the edentulous posterior maxilla had ≤ 4 mm of bone crestal to the 
sinus at 43% of the proposed implant sites.81 
         Several procedures and materials have been developed  to overcome 
the problem of reduced amount of bone Kaufmann E (2003)69 like tilted 
implants, short implants & vertical bone augmentation. But lesser success rates 
have been reported with tilted implants74 and short implants.115,61 
Many techniques have been introduced addressing vertical bone 
augmentation like sinus floor elevation (SFE) from a lateral window or SFE from 
a crestal approach using osteotomes, onlay graft, guided bone regeneration, 
appositional bone graft/saddle-graft or combinations of these techniques. Today, 
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Sinus augmentation has become a standard procedure to increase bone height in 
the posterior maxilla13, thus allowing placement of long dental implants. 
 The report of the 1996 consensus conference by the academy of 
osseointegration cited successful sinus augmentation results utilizing various 
forms of graft materials. Nicolaas MT et al., (1997) 95stated that elevation of 
maxillary sinus floor using bone grafts in patients free of sinus problems with no 
radiographic evidence of pathologic disease does not induce sinusitis following 
sinus augmentation 
Today, two main procedures are used for sinus floor elevation and implant 
placement namely the ‘Lateral window approach’, first presented in (1977)129 by 
Tatum and published in (1980)13 by Boyne and James and the ‘Transcrestal 
approach’ Techniques which was described by Summers RB in (1994)122 using 
tapered osteotomes with increasing diameters. Bone may conserved in this method 
since no drilling is involved. Follow up of this procedure with large number of 
press fit implant were tried by Rosen in (1999)110 with a success rate of 96% at 
the end of 1 ½  years.  
             Though good implant survival rates are being reported with these 
procedures, the postoperative morbidity was noticed to be higher with these 
techniques.149,45 Hence, modifications of these techniques have been suggested by 
various authors and thus the ‘Minimally-invasive Techniques’ have come to 
stay37,77,78.The search towards the least-invasive method for sinus augmentation 
lead to the evolution of the “The innovative implant technology (IIT) Sinu-
LiftTM System” -one of the very minimally invasive indirect sinus lift instrument. 
This system is intended to safely lift the sinus membrane through a crestal 
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approach without compromising the integrity of the sinus membrane. The 
components of the Sinu-LiftTM system are designed to decrease the air cavity in 
the maxillary sinus by lifting the membrane from the proximal surface of the 
maxilla in order to allow for bone grafting into this area to supplement the 
maxillary alveolar ridge with additional height needed for placing a dental 
implant. 
         Various materials are currently available for sinus grafting to create stable 
implant beds. Purely synthetic resorbable materials such as β -tricalcium 
phosphate (TCP) (first substituted by Tatum in 1986) does not involve the 
potential risks that products of biological origin carry. Furthermore, in contrast to 
autologous bone grafts, they do not require any second stage surgery 
                             Cerasorb® M (Curasan AG, Kleinostheim, Germany) , a 
pure-phase (> 99 percent) synthetic β -TCP developed on the basis of 
Cerasorb®M, a well-known product that has yielded good results.124,56,113 Owing to 
its physical properties like interconnecting open porosity, polygonal nature of the 
particles, multiporosity (approximately 65 percent) and induction of complete 
resorption. β –TCP, in addition to its chemical and biological advantages, along 
with its bone like radio opacity allows accurate evaluation following its 
placement.  
                             The use of bone substitutes can become more predictable if they 
are used in combination with growth factors, which have the capacity to accelerate 
deposition of new bone in association with the graft material, thereby shortening 
the time to achieve adequate consolidation.141 Platelet-rich plasma (PRP), which is 
a volume of plasma with a concentration of platelets85, has been suggested to 
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increase the rate of bone deposition and bone volume in combination with bone 
grafts when used during augmentation procedures.111   
                    Therefore, a combination of PRP with β -TCP may result in an 
increased rate of bone formation and sinus augmentation procedure.147Hence the 
present study was undertaken to augment the floor of maxillary sinus with β- TCP 
(Cerasorb® M) in conjunction with P.R.P and to assess the same with clinical 
and radiographic evaluations. 
     
  
 
Aims  &  Objectives      
5 
 
 
AIMS : 
• The aim of present study is to clinically & Radiographically evaluate 
maxillary sinus floor augmentation using bone graft β-Tricalcium 
phosphate (Cerasorb®M) in conjunction with autologous Platelet Rich 
Plasma (PRP) - using the “Sinu-Lift TM System”. 
 
OBJECTIVES : 
• The radiographic assessment of the gain in vertical height of alveolar ridge 
of the maxillary alveolar crest after the procedure with the aid of OPG and 
C T scan. 
• To assess the changes in Bone Volume and Bone Density. 
• To assess post-operative morbidity of this procedure. 
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REVIEW OF LITERATURE 
A minimum of 10mm of bone height is required for predictable implant 
survival89,33.Implants less than 10mm are less successful than longer implants115,61  
Rosen et al.,(1999)110 & Peleg et al (2006)104- Failure rates of implants 
stabilized in 5mm or less of residual bone was shown to be significantly higher 
than those placed in more than 5mm of residual bone height.  
When less than 5mm of residual bone remains between the alveolar crest 
and the maxillary sinus, traditional treatment option of choice prior to implant 
placement is ‘subantral augmentation’, which can be performed in one or two 
surgical stages depending on the height of the residual alveolar edge. The two 
stage procedure is recommended for bone height less than 5mm (Jenson OT, 
1999)62. This allows healing of the graft material for future implant sites (Smiler 
DG et al 1992)118.  
The major drawback of the one stage technique is challenge of achieving 
initial implant stability and parallelism, which ultimately could jeopardize the 
implant success (Kan JY et al 2002)65, though there are reductions in chair time, 
cost and number of surgical procedures Blomqvist JE et al (1996)12. 
The risk of implant failure in grafted areas for the 1- stage procedure was 
greater than for the 2-stage procedure.135,144,82116. 
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POSTERIOR MAXILLARY ATROPHY 
Garg A (1994)46, Thomas GJ (1990)131 –After tooth extraction, the initial 
decrease in bone width is due to resorption of buccal bony plate. As edentulous  
area continues to atrophy, there is a continuing loss of bone height and density and 
an increase in antral pneumatisation.  
Lekholm & zarb (1985)76In addition, maxillary is made primarily of 
spongy bone and the reduced bone quality results in more resorption. 
It is therefore common to find the sinus floor close to the alveolar crest and this is 
related to two phenomena.  
1. Kraut R et al (1989)73, Chanavaz M et al (1990) 22 –Enlargement of the 
sinus at the expense of the alveolus after tooth extraction because of 
increased osteoclatic activity of the periosteum of the Schneiderian 
membrane. 
2. Smiler DG et al (1992)118 - Increased pneumatisation of the sinus because 
of increase in positive intraantral  pressure  
  Tallgren A et al (1972) 126- The duration of the edentulism is decisive for the 
extent of alveolar ridge resorption and antral pneumatisation of the alveolar 
process 
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ANATOMY AND PHYSIOLOGY OF THE MAXILLARY SINUS 
The maxillary sinus (antrum of high more) is pyramidal in shape and is the 
largest of the paranasal sinuses (Hollinshed WH)54. There is a wide range in sizes 
and shapes of maxillary sinus.  
Vandenbergh et al (2000)141-The average dimensions of the sinus are 
36to 45mm in height, 25 to 35mm in width and 38-45mm in length  
It has an average width of 35mm and average height of 25mm (Small SA 
et al 1993)117. 
Uchida et al (1998)137- The average total maxillary sinus volume  was 
13.6 ± 6.4cc  
The size of the sinus and especially the angulation between the medial and 
lateral wall of the maxillary sinus (Cho et al 2001)27 seemed to exert a large 
influence on the incidence of membrane perforations during sinus floor elevations.  
Misch C Eet al (1999)90 - The maxillary sinus is surrounded by six walls. 
The base of  pyramid is the medial wall of the sinus that  is also the  lateral wall of 
the nasal cavity and its apex  pointed towards zygomatic bone. The roof of the 
sinus is also the floor of the orbit. The sinus  floor may extend between the roots  
of maxillary molars.  
Maxillary sinus septa : Underwood AS 1910138, showed a prevalence  of 33% of 
this anatomic variation and the prevalence was significantly greater in atrophic 
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edentulous regions. The incidence of antral septa varies  between 76% and 58% 
and is classified into primary and secondary septa (Krennmair G et al 1997)75.  
          Pikos M .,(1999)106 and Kim et al., (2006)71 reported that the prevalence 
(26.6%)of primary septa was found to be significantly higher. The presence of the 
septa increased the risk of sinus membrane  perforation during sinus floor 
elevation procedures.  
Schneiderian Membrane: The normal width of the schneiderian membrane 
(pseudostratified columnar epithelium, the connective tissue and the periosteum 
collectively) is generally 0.3 to 0.8mm Mogensen et al (1977) 91.  
          Vandenbergh JPA et al (2000)141When alveolar bone is totally absent in 
some places, the membrane cannot usually be kept intact leading to perforations. 
And also he reported that the variety of anatomical modalities in shape of the 
inner aspect of the maxillary sinus defines the surgical approach.  
Maxillary Ostium : The Ostium in the opening from the sinus to the middle 
meatus  of the nose. It is situated on the superior aspect of medial wall of 
maxillary sinus above the first molar. The mean distance from most inferior point 
of antral floor of ostium is 28.5mm Uchida Y et al (1998)137.  
Vascular supply: Three arteries supply the maxillary sinus, the posterior superior 
alveolar, infraorbital and the posterior lateral nasal arteries, all of which are 
branches of maxillary artery. Knowledge of the blood supply is of importance in 
sinus floor elevation procedures in terms of incision placement, vascularization of 
the sinus graft and the location of that blood supply relative to the position of the 
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required lateral osteotomy. Solar P et al., (1999)119 reported intraosseous 
anastamosis in 53% of the CT Scans & extraosseous anastamosis in close contact 
with the bone in 44%  
Microbiota :In addition to the normal commensal microbiota of the maxillary 
sinus like streptococcus and Neisseria species, varying amounts of staphylococci, 
diphtheroids, Haemophilus spp., pneumococcis and mycoplasma are also found  
in varying amounts Timmenga et al (2003)95.  
The healthy maxillary sinus is self maintaining by postural drainage and the 
integrity of the sinus membrane is essential. The muco ciliary apparatus protects 
the sinus against infection by removing the organisms trapped in the mucus 
through the ostium. The membrane also acts as a biologic barrier, and an 
increased chance of infection results if the  membrane perforates.  
VARIOUS SINUS LIFT (AUGMENTATION)TECHNIQUES : 
1. Lateral Window techniques  
2. Crestal approach techniques  
1. LATERAL WINDOW TECHNIQUES  
The most commonly used bone augmentation technique is the SFE  from  a lateral 
window, which was first presented  by Tatum in (1977)128 and first published by 
Boyne and James in (1980)13 .Tatum changed his initial technique of SFE from a 
complex crestal access to a more verstaile and practical technique of a lateral 
access. The long term success of this often modified augmentation  procedure has 
been documentated. Tong DC et al (1998)133, Jensen OT et al (1998)62.  
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Drawbacks :Though widely used today and implant survival rates associated with 
this procedure routinely exceed 90%, the lateral window sinus lift remains a 
technique sensitive procedure due to the high risk of schneiderian membrane 
perforation8,9,118 and hemorrhagic complications, the latter of which is associated 
with the inadvertent laceration of the intraosseous arterial supply to this region 
(Solar P et al (1999)119, Vercellotti T (2004)142. It also requires raising of a large 
flap for surgical access147.  
Perforation rates associated with the lateral sinus window or curette 
elevation of the Schneiderian membrane range from 11% - 56%27,43,102,130,53. This 
complication is noteworthy because excessively large perforations may necessiate 
the abortion of the procedure, cause a delay in treatment (Testori T et al 2008130) 
or necessitate an additional treatment associated with direct communication into 
the sinus. In the event that Schneiderian membrane perforations may be repaired, 
additional costs are necessary (e.g incorporating the use of GTR membrane for 
graft containment)  
Neiva RF et al (2004)94 - Because the bony thickness of lateral maxillary 
sinus walls averages 0.91mm, and the adjacent Schneiderian membrane averages 
0.15mm in thickness, the traditional use of high-speed rotating instruments for the 
preparation of lateral sinus antrostomies required exacting attention to detail.  
 Zijderveld et al.,(2008)149 In addition to these, iatrogenic complications 
like a) injury to infraorbital neurovascular  bundle from deep dissection to free the 
flap, b) implant migration, c) haematoma and adjacent  tooth sensitivity, d) 
infection of the grafted sinuses e) sinusitis f) wound dehiscence and g) late failure  
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reports like chronic infection, graft exposure, loss of entire bone graft, oroantral 
fistula, ingrowth of soft tissue through the lateral window and sinus cysts were 
reported  with the lateral window technique  
2. CRESTAL APPROACH TECHNIQUES :   
A more conservative and less invasive approach for the conventional 
lateral approach introduced by Tatum in (1986)129 and modified by Summers 
(1994)122 This Technique is recommended for Type-III & IV bone. Concave 
tipped ostetomes of increasing diameter applied via crestal approach advanced a 
mass of bone beyond the level of the original sinus floor, elevating the mucosal 
lining. If bone graft material is added,it is Bone added osteotome sinus floor 
elevation-. BAOSFE  (Summers 1994122,Rosenetal ,1999110).Summers described 
one stage (atleast 6mm of residual bone) or two stage approach (for cases less than 
6mm residual bone height). 
Surgical techniques for sinus floor elevation using transcrestal approach 
are mainly based on the  fracture or perforation of sinus floor by means of 
osteotomes 34,30,35 or burs31,120  
Fugazzotto PA (2002)42- Pristine bone at sites of implant placement 
drilled upto the sinus floor by using a trephine bur and used to fracture the sinus 
floor with hydraulic pressure through osteotomes.  
Systematic reviews by Wallace SS & Froum SJ (2003)143, Emmerich D 
(2005)38, and Tan WC et al (2008)127 – showed  that sinus augmentation  
procedures used transcrestal approach were associated with considerable long 
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term stability and reported a success rate of 95.75 and 96.0% after 24 & 36 
months respectively but reported with perforation rates. 
Cannizzaro (2009)20 - Compared a ‘crestal’  sinus lift procedure with 
autogenous bone and 8mm long implants with a ‘lateral window’ sinus lift with a 
mix of autogenous bone and 50%  Bio-Oss to place longer implants. Though no 
statistically significant differences were found, there were more complications and 
failures with the lateral window augmentation procedure. It is interesting  to 
observe  that all implants were placed in bone with a residual height of 3 to 6mm 
and were loaded less than 2 months after sinus lift. 
Though good implant survival rates have been reported. the transcrestal 
approaches using osteotomes had the following disadvantages 
Disadvantages with Osteotomes ;  
A) when a thick layer of alveolar bone remains coronal to the sinus floor, the 
technique may require extensive malleting trauma  during sinus floor elevation, 
which eventually causes (BPPV) Benign Paroxysmal Positional Vertigo -                   
Galli M et al (2002)45, Rodriguez et al (2007)108 
B). The chances of achieving a sufficiently high elevation with the osteotome 
technique is limited. -Zitzmann NU. et al., (1998)151. 
C) The action of osteotomes can hardly be controlled during the  application of 
malleting pressure resulting in an  unwanted penetration of the instruments and/or 
graft in the sinus cavity with a potential membrane perforation.  
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Tan WC et al.,(2008)127 reported incidences of membrane perforations 
ranging from 0% - 21.4% & post-operative infection from 0% - 2.5% respectively 
Raiser GM et al (2001)107 reported that perforation rate of 24% with the 
risk increasing according to increase in extent of sinus floor elevation 
Nkenke E et al (2002)98 – proposed the endoscopically controlled sinus 
floor elevation technique (ECOSFE). The osteotome technique even when applied 
selectively and endoscopically controlled, yields modest antral membrane 
elevation, required considerable skills and frequently may result in membrane 
tear.  
So, the use of burs  with different working length provides a controlled 
perforation of the sinus floor, restraining the action of the cutting edge to the 
native bone  and limiting the risk for perforation of the sinus membrane.  
The major novelty resides in the fact that all manual and rotating 
instruments  are used with adjustable stop devices that restrict  the working action 
of burs  and osteotomes  to the vertical amount of residual bone, thereby 
preventing the accidental penetration of instruments into the  sinus cavity. 
            So, recently many alternative  minimally invasive techniques  have been 
proposed to limit the postoperative morbidity associated with conventional lateral 
window or osteotome techniques. 
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MINIMALLY INVASIVE TECHNIQUES OF SINUS LIFT :  
Chen L , Cha J (2005)25 - made an 8 year retrospective study in 1100 
patients receiving  1557 implants using the minimally invasive hydraulic sinus 
condensing  technique and had favorable results.  
Efraim Kfir et al (2007)37 - proposed a report  on minimally invasive  
technique with antral membrane balloon elevation technique. The dedicated 
device was screwed in upto 0.5mm superior to sinus floor and balloon was slowly 
inflated and the deflated after the referred elevation with the inflator syringe 
(using  contrast medial 50% contrast material diluted with normal saline). It 
seemed to have a high procedural success, a low rate of membrane perforation, 
and a very acceptable complication rate. Requires a relatively short learning curve 
and provides the patient  with early functional implants.  
Trombelli L et al (2008,2010)77,78 - proposed the  smart-lift technique 
characterized by  transcrestal approach by means of specifically designed 
instruments with adjustable stop devices. The augmented sites had a presurgery 
residual bone height of 6.1mm whereas  the mean length of the implants inserted 
in the augmented sites was 10.3±0.9mm. No complications  were observed during  
or after the surgical procedure.  Six months after, a newly formed mineralized  
tissue was found at or beyond the  level of the implant apex in all cases.  
Steiner G G. et al.,(2010)121 Presented a simple non-traumatic sub-antral 
sinus lift microsurgery which allows the sinus to be entered at its lowest point 
through a 3 to 4 mm osteotomy, significantly reduces surgical trauma.  
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Materials used for Sinus Augmentation 
 Several grafting materials have been used in sinus augmentation 
procedures including Autografts, Allografts, Xenografts, Alloplastic materials and 
a combination of these materials and others.  
 According to Kent and Block (1997)70, an ideal grafting material should 
fulfill the following criteria 
- Osteoinduction , Osteoconduction &Volume stability 
 AUTOGENOUS BONE GRAFTS is very successful in bone regeneration 
and serves as the gold standard (Goulet et al 1997)48. However, though intraoral 
donor sites like chin and ramus are convenient, they yield limited volume 
(Kalk,199664 & Goulet etal.,1997)48. Extra oral donor sites like iliac crest, tibia 
etc., increase the surgical complexity and are associated with significant morbidity 
and scarring (Kaptein ML et al 1998)66. In addition, uncontrolled resorption of 
graft material results in loss of volume in the gained augmentation height after 
sinus graft procedure. Schlegel K A etal.,(2003)114 
Therefore, alternative grafting materials have been developed.  
 ALLOGRAFTS FOR SINUS AUGMENTATION : Harvested from 
cadaveric donors and subjected to various techniques like freeze drying and 
irradiation to reduce the anti-genicity (Eg.)DFDBA (De-mineralized Freeze Dried 
Bone Allograft) with BMP’s (Nishibori M et al 1994)97 in sinus augmentation 
procedures.  
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Claudio Stacchi et al (2008)29 - Made clinical, histologic and 
histomorphometric analysis of regenerated bone in maxillary sinus augmentations 
using fresh frozen bone allografts (FFBA) and concluded it as a biocompatible 
material for sinus augmentation without interfering with normal reparative bone 
process.  
Chaushu et al (2009)23  - Cancellous block allograft seems to possess  the 
potential as a grafting material for sinus floor augmentations with implant 
placement  in cases with residual alveolar ridge height of ≤4mm.  
However, there remains some concerns associated with their use, including 
cost and there can be residual immunological  risks as well as the risk of the host 
obtaining a graft transmitted infection - Becker W et al (1995)10 
 XENOGRAFTS : Xenogenic bone grafts has proved to have satisfactory 
osteoconductive properties 
Hallman et al.,(2002)51 reported higher survival rates for implant placed 
into sinuses grafted with 100% xenografts whereas Froum et al., (1998)40 
reported statistically significant increase in vital bone formation after SFE using 
combination of xenografts with autogenous bone or DFDBA 
Carlos E.A Ferriara et al (2009)21 - Made a clinical study of the 406 
sinus augmentations with 100% anorganic bovine bone (ABB) associated with a 
collagen membrane (CM) for a sinus graft by means of clinical, histologic and 
radiographic parameters in cases with bone availability ≤ 7mm and showed an 
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excellent and predictable survival rate of 98% of implants placed in these grafted 
sinuses.  
 In dental practice, xenografts has suffered from ethical  controversies 
thereby reducing its use drastically -Butler et al., (1998)19 
ALLOPLASTIC MATERIALS FOR SINUS AUGMENTATION :  
 Alloplastic materials are widely used nowadays as they are in unlimited 
resources, easy to handle and do not demand additional surgical procedures. 
Examples are hydroxyapatites, calcium phosphates (β-TCP), bioactive glasses and 
calcium sulfate  
HYDROXYAPATITES : HA’s used for sinus lifting procedures have 
proven reliable with long term results showing stable osseointegration of installed 
dental implants  
Rolf Ewers et al.,(2004)109 - Compared the  histologic findings at 
augmented bone areas supplied with two different bone substitute material 
combined with sinus floor lifting of BioOss  (an organic bovine bone substitute) 
with Algipore (a porous algae derive HA) and showed that BioOss showed no 
evidence  of substantial remodeling after a healing period of 4.5 years whereas, 
Algipore was locally resorbed and replaced partially with newly formed bone 
within 6 months. 
 Though the material is well known for its osteoconductivity , It wasn’t 
resorbed in proper time and  healing was delayed (Artzi Z etal.,2004)5 and thus 
interferes with bone remodeling process  
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β-TRICALCIUM PHOSPHATE, a CaPO4 bioceramic : Among various 
bone substitutes, pure phase β-TCP is  a promising material for augmentation of 
the maxillary sinuses (Zerbo IR et al (2004)148, Merten Ha et al (2003)88, Szabo 
G et al (2005)124- as has been shown in multiple publications  
          Chazano et al.,(2004)24 -Particles of β – TCP appears a very interesting 
biomaterial for sinus lift elevation since it does not induce inflammation, favours 
osteoconduction and is highly degraded by macrophage land osteoclasts. The 
morphology of the granules (with macroporosity) ensures a suitable space for 
vascular sprouts and for osteoprogenitor cells invasion.  
Kotani et al., (1991)72 - Numerous reports have confirmed that a direct 
bone opposition can be observed at the surface of β – TCP without interposition of 
a HA layer.  
Hsu et al., (2007)58 - The 3D arrangement of granules is also a factor that 
favors osteoconduction.  
Szabo G et al., (2001)123 - In contrast to Bio-Oss, that β-TCP is fully 
resorbed in 12-18 months and is replaced by bone that is similar both functionally 
and anatomically to original bone.  
Artzi Z et al., (2004)5, A 24 month histomorphometric animal study 
reported that bovine derived graft materials were not resorbed in the meant time 
and healing was delayed when compared to pure phase β -TCP grafted defects 
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CERASORB® M  : (Curasan AG, Kleinosthein, Germany)  
A pure phase (> 99%) synthetic β-TCP developed on the basis of 
Cerasorb®, a well known material that yielded good results for many years.  
Szucs et al., (2000)125 - Demonstrated in a sample of 52 patients  treated 
for a variety of indications that Cerasorb®  completely transformed to bone within 
12 months of augmentation creating a stable bed for implant within 4to 6 months   
and concluded that the use of autologous  bone for sinus grafting was no longer 
necessary because Cerasorb® had proved its  ability to cover these applications  
on its  own. This conclusion has been supported by numerous authors –
Palti.,(2002)101 ,Horsch HH et al (2006)56, Schermer ST .,(2006)113, Szabo G et 
al .,(2005)124.  
Palm F et al., (2006)100 -  An open single centre  study involving sinus 
grafting with Cerasorb® M in 58 patients . Cerasorb® M is an ideal synthetic 
material characterized by porosity similar to natural bone. The material was 
resorbed while native bone was newly forming allowing for implant placement 
within 4 to 6 months.  
Szabo et al.,(2005)124  - performed bilateral sinus grafting on 20 selected 
patients. Cerasorb® was used on the experimental side and autogenous bone was 
used on the control side. In 10 of the 20 patients, 2-D and 3-D CT examinations 
were performed pre and postoperatively and after implantation. Histologically and 
histomorphometrically , there was no significant difference between the 
experiemental and control grafts in terms of the  quantity and rate of ossification. 
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Comparisons with other studies reveal that β – TCP (Cerasorb®) is a satisfactory 
graft material, even without autogenous bone.  
Zerbo et al.,(2004)148 - examined the use of a porous β – TCP in a split 
mouth model for sinus floor augmentation. Five patients were treated bilaterally, 
receiving 1-2mm sized β – TCP particles (Cerasorb®) on one side and autologous 
chin bone particles on the other side. The average bone volume formed in the 
augmented sinus at the control site was 41% and 17% in the test side. Osteoid 
formation tended to be higher in test side biopsies (1.3%) than in the controls 
(0.3%) indicating ongoing bone formation in the TCP material. The histological 
results indicated that Cerasorb is an acceptable bone substitute material for 
augmentation of the maxillary sinus.  
Zsuzsanna Suba, eta al.,(2006)153-Cerasorb® proved to be an effective 
bone-replacing material with osteoconductivity; it was capable of gradual 
disintegration,thereby providing space for the regenerating bone. Six months after 
insertion of the grafts, the bone of the augmented sinus floor was strong and 
suitable for anchorage of dental implants, irrespective of whether autogenous bone 
or Cerasorb® particles had been applied 
Zijderveld et al.,(2005)150 - conducted a clinical study to determine the 
clinical and histologic bone formation ability of 2 graft materials, β – TCP 
(Cerasorb®) and autogenous chin bone, in maxillary sinus floor elevation surgery. 
Ten patients underwent a bilateral or unilateral maxillary sinus floor elevation. In 
bilateral, the original bone was augmented with a split-mouth design with 100% , 
β – TCP on the test side and 100% chin bone on the contralateral control side. The 
 
Review of Literature 
22 
 
unilateral cases were augmented with 100% β – TCP. According to the clinical 
results, the pre implantation sinus floor procedure which involved a limited 
volume of β-TCP, appeared to be a clinically reliable procedure. Radiographic 
evaluation with a follow-up of 4.5 yrs shows that no statistical differences 
between the above said two types of grafts in relation  to gain in vertical bone 
height 
Zerbo  and co-workers.,(2004)148, Szabo G et al.,(2001)123   showed that 
β-TCP is an acceptable bone substitute material, but the rate of bone formation is 
delalyed in comparison to autologous bone. Consequently, the use of  bone 
substitues can become more  predictable if they are used in combination with 
growth factors, which have the capacity to accelerate deposition of new bone in 
association with graft material, thereby shortening the time to achieve adequate 
consolidation.-Vandenbergh JP et al.,(2001)140 
PLATELET RICH PLASMA IN SINUS AUGMENTATION PROCEDURES  
 According to Marx85, who first reported on the applications and clinical 
benefits of platelet rich plasma in 1998, PRP is “a volume of autologous plasma 
that has a platelet concentration above baseline.” Platelet rich plasma is an 
autologous source of concentrated platelets obtained by sequestering and 
concentrating platelets by gradient density centrifugation26,36. The α granules 
begin secreting these growth factors within 10 minutes of the initiation of blood 
clotting and within 60 minutes, 95% of these factors are released87. The granules 
in platelets contain high concentrations of different growth factors, including 
platelet- derived growth factor, TGF-β1 and -β2, insulin-like growth factor-I, 
 
Review of Literature 
23 
 
vascular endothelial growth factor, epithelial growth factor and platelet activating 
factor-4.79 Released growth factors such as PDGF, TGF β etc., have been shown 
to have an osteoregenerative effects because of their proangiogenic activity and 
differentiation effects on osteoblasts. TGF β also decreases bone resorption by 
inducing osteoclastic apoptosis. 
 Kassolis et al.,(2000)67- used PRP with bone substitutes in sinus floor 
elevations with good post-operative results.  
Wiltfang J & coworkers.,(2003)146 - showed statistical significantly 
higher  regeneration in test sites (β-TCP combined with PRP)  compared with 
control sites (only β-TCP) (38% v/s 29%, respectively) after 6 months and 
concluded that the rate of bone formation  was faster due to addition of PRP and 
bone substitutes  like β-TCP. It was also stated that instead of autogenous bone, β-
TCP could also be used in conjunction with PRP for sinus augmentation 
procedures.  
Holtz W., (2005)57 - The use of PRP with Cerasorb® has advantages like 
accelerated mucosal healing and reduced pain especially in the early postoperative 
course, thus minimizing the use of analgesics and expediting bone regeneration 
down the road.  
Kovacs, KatalinVelich et al.,(2003)68 made an experimental comparative 
study of β-tricalcium phosphate mixed with platelet-rich plasma versus β-
tricalcium phosphate alone and concluded that In week 6, bone formation was 
already more effective when PRP was applied in comparison with β-TCP alone, 
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and in week 12 the growth was significantly greater. The results demonstrate that 
the use of PRP accelerates the remodeling of new bone created by β-TCP. 
          Navneet S Arora et al.,(2010)92 There is a paucity clinically controlled 
trials regarding benefits of PRP in sinus augmentation procedures. Theoretically, 
it seems to have significant beneficial  effects on the soft and hard tissue healing 
The disparity in study design, surgical techniques  and different outcome 
assessment variables used, makes it difficult to assess the   practical benefit  of its 
clinical use. However, the handling of the bone grafts was improved when  PRP 
was used in  sinus augmentations. 
           Nazaroglou E et al.,(2009)93- Though controversies exists, many proved 
that PRP is able to provide good results provided all the other parameters which 
influence the bone regeneration are optimal. 
OTHER NEWER AUGMENTATION MATERIALS:  
          Other materials like  Stem cell based sinus augmentation procedure 
(Bradley S et al 2009)15, Chaukron’s Platelet Rich fibrin (Ziv Mazor et al 
2009)152,Recombinant human BMP2 incorporated in bone substitutes (Gilbert R 
et al 2009)47, tissue engineered bone grafts combined with Xenografts (Beaumont 
et al 2008)28, have reported with  successful implant survival.  
Maxillary sinus function after sinus augmentation 
          In patients without preexisting sinus problems, no acute symptoms were 
induced, nor did symptoms developed during the 12-60 months follow up period – 
Nicolaas M et al., (1997)95 
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 Ofer Mardinger et al., (2009)84 reported that average patients undergoing 
sinus augmentations  usually percepted  post operative recovery within 5 days  
 Griffa Alessandro et al.,(2010)49 reported that Mucociliary function is 
preserved even during the surgical procedure except for the detached area of the 
schneiderian membrane. 
Computerized Tomography evaluation in Sinus augmentation: 
Computed tomography (CT) provides a more accurate visualization of 
anatomical structures without super-imposition and allows for a continuous view 
of surface topography while preserving the soft tissue detail.145 It has been 
reported that the thickness and width of the alveolar bone and then process of new 
bone formation could be better assessed with sagital and axial images from CT 
than with a panoramic radiographic image when planning surgery123.  Low dose 
CT protocols like cone beam CT may also be applied as alternative. Reducing the 
tube current and voltage followed by using 1.5mm slice thickness instead of 1mm 
decreases the radiation dosage to the patient.44 
A comprehensive implant treatment plan is determined and a post-
operative assessment of cancellous and cortical bone is achieved with CT. 99,103 
So, CT is an excellent technique to delineate the osseous structures of the bone32  
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ABC SINUS AUGMENTATION CLASSIFICATION 
(Wang & Katranji 2008)55 
Class 
Location of 
Sinus floor 
from the crest 
of bone (mm) 
Width 
(mm) 
Distance 
from bone 
crest to 
adjacent CEJ 
(mm) 
Recommended 
procedure 
Class A 
(Abundant 
bone) 
10 5 or greater 3 or less Implant placement 
Class B 
(Barely 
sufficient 
bone) 
6-9 5 3 or less Osteotome 
Division H 
(Horizontal 
defect) 
6-9 Less than 5 3 or less 
Osteotome and 
Ridge expansion 
GBR/Onlay graft 
Division V 
(Vertical 
defect) 
6-9 Greater than or equal to 5 More than 3 
GBR followed by 
Osteotome 
Division C 
(Combined 
defect) 
6-9 Less than 5 More than 3 
GBR and/or onlay 
graft flowed by 
Osteotome 
Class C 
(Compromised 
Bone) 
5 or less 5 or more 3 or less Lateral wall sinus elevation 
Division H 
(Horizontal 
defect) 
5 or less Less than 5 3 or less 
Lateral wall sinus 
elevation & 
GBR/onlay graft 
Division V 
(Vertical 
defect) 
5 or less Greater than or equal to 5 More than 3 
Lateral wall sinus 
elevation & GBR 
followed by Onlay 
graft (if indicated) 
Division C 
(Combined 
defect) 
5 or less Less than 5 More than 3 
Lateral wall sinus 
elevation & GBR 
followed by onlay 
graft (if indicated) 
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METHODOLOGY 
Patient Selection 
 The present study group comprised of ten systemically healthy patients            
(6 males and 4 females) in the age range of 25-55 years, with referral to the 
Department of Periodontics, Ragas Dental College & Hospital, Chennai for 
implant placement in the posterior maxillary edentulous area. Once the patient 
was found to be suitable for the study, the entire study protocol was explained in 
detail to the patient and consent was obtained. 
Inclusion Criteria ; 
Patients were selected using the following criteria : 
A).Partially edentulous jaws, with a unilateral or bilateral loss of teeth in the 
maxillary pre-molar or molar area. 
B).The remaining dentitions were intact, with healthy periodontium, with teeth 
adjacent to edentulous areas good in health or treated with minimal class I or II 
restorations  
C).Patients with acceptable oral hygiene status and no active  periodontal disease. 
D). The main criteria for inclusion in the study group was a residual alveolar ridge 
height of 5mm or less  as evaluated by pre-operative panoramic radiographs, 
computed tomographic scans and  those that needed no buccal–lingual 
augmentation. 
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E). According to the ABC sinus augmentation classification Class C division-V 
(vertical defect);             
  i . The bone crest is 5mm or less from the sinus floor. 
                       ii.The bone width is 5mm or more 
                      iii.The bone crest is more than 3mm from the adjacent CEJ.  
F).The decision to rehabilitate the missing teeth with implant supported prosthesis 
was made and the patients required sinus augmentation prior to implant 
placement. 
G).Each patient was given a  detailed description about the treatment and the 
clinical procedures were explained. 
H).A written informed consent was obtained from the patient before the onset of 
the clinical procedure. 
I). The Ethical review committee of Ragas Dental College & Hospital, Chennai, 
approved the study design. 
Exclusion Criteria ; 
After a thorough review of the medical history, following patients were deemed 
unsuitable to undergo sinus augmentation procedures.  
A).The presence of uncontrolled diabetes, autoimmune diseases or any 
Contraindicating systemic conditions 
B).Radiation therapy to the head and neck region in 12 months prior to the 
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proposed therapy  
C).Chemotherapy in the 12 months prior to the proposed therapy  
D).Uncontrolled periodontal disease or/an unwillingness to undergo needed     
periodontal therapy around the remaining teeth  
E).Active sinus infection or an history of persistent sinus infections  
F). Smokers  
G).A psychological problem that would have rendered the delivery of 
comprehensive therapy unattainable  
H).An unwillingness to commit to a long term post therapy maintenance    
     program  
I). Patients with deprived platelet content  
J). Patients on long term steroid use  
K).Patients with blood disorders  
L). Patients with any drug abuse, including alcohol  
M). Inadequate opening of patients mouth.  
N). Height of alveolar ridge of maxillary alveolar crest is less than 5mm.  
O). Uneven anatomy of maxillary sinus floor.  
P). Presence of maxillary sinus pathologies.  
Q).When the septum is present at the location where sinus membrane lift is 
desired.  
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Pre-Operative Diagnostic Evaluation 
Clinical Examination 
 At the initial visit, all patients underwent a clinical and occlusal 
examination. An oral hygiene assessment of the patient was performed. The 
edentulous area in the posterior maxilla was examined and the ridge width and the 
mesio-distal diameter were checked. Patients who had an acceptable ridge width 
were further evaluated radiographically. Periodontal health status was assessed for 
the neighboring teeth on either side of the edentulous ridge. 
Radiographic Examination 
 The preoperative radiographic evaluation included periapical and 
panoramic radiography . A computerized tomography scan (C T Scan) of the 
posterior atrophic maxilla was also done. The CT scan was done using a multi 
detector light speed plus CT scanner (GE Electricals, Milwakee, WI, U.S.A) 
 A Constant thickness of 64 slices per second was obtained with the tube 
voltage being 80KV. All necessary precautions were taken to protect the patient 
from radiation exposure in addition to reduced tube voltage and 1.25mm slice 
thickness. Residual alveolar bone height was measured from the CT scan using 
the inbuilt software and measuring tools in the areas of missing posterior 
teeth.Subsequently, an OPG with a metal ball stent was taken to evaluate the 
vertical height from an arbitrary horizontal line joining the CEJ from the adjacent 
teeth to the floor of the sinus lining.  
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The following three points were marked on the arbitrary horizontal line joining the 
CEJ. 
Point A : 2mm from the mesial tooth  
Point B : Midpoint from the line joining  point A and C 
Point C : 2mm from the distal tooth 
 From the points mentioned above, a vertical arbitrary line was drawn to 
the floor of the maxillary sinus lining and the values were recorded. 
Preoperative Casts and Bone Mapping 
 An impression of the maxillary arch was made using alginate impression 
material and poured in dental stone. Bone mapping was done to determine the 
width of the alveolar ridge.  
Preparation of P.R.P:  
• Patients were taken to the Ragas General Hospital Laboratory one 
hour before surgery, 20 ml of blood was drawn from all patients  
through a venepuncture in the antecubital vein.  
• The drawn blood was collected in two sterile test tubes, 10 ml in 
each test tube containing 1 ml of 10% trisodium Citrate anticoagulant 
solution.  
• The glass tubes containing blood were centrifuged at 1200 rpm for 20 
minutes, which resulted in the separation of the two fractions; plasma at 
the top and red blood cells at the bottom. The plasma, along with the top 
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2ml of red blood cells, was aspirated with the help of “Eppendorff 
pipettes”. This fraction was again centrifuged at 2000 rpm for 15 minutes 
to get three basic fractions; platelet-poor plasma (PPP) at the top of the 
preparation (supernatant), PRP in the middle and the red blood cell 
fraction at the bottom. The top 80% fraction corresponding to PPP was 
aspirated with a pipette, leaving the residual (0.5 -2 ml) platelet 
concentrate.- Marx RE & Garg AK., (2005).86 
• The PRP was collected from each tube to ensure the largest and the 
newest platelets were collected.  
• Then the coagulation of PRP was obtained by adding 1 ml 
Batroxobin  (Botropase) and 1 ml of 10% Calcium Gluconate which 
was shaken in a sterile tube for approximately 30 seconds to obtain 
within a minute or so a gel to be mixed with the bone graft and 
applied to the surgical site.  
Surgical Technique & Procedure : 
 All Patients were administered a dose of prophylactic antibiotic 
(Amoxycillin 2gms 1 hour before the surgical procedure) prior to sinus floor 
augmentation surgery. They were made to rinse their oral cavity with 0.2% 
chlorhexidine for 2 minutes. The sinus augmentation was then carried out 
according to the surgical protocol.   
• Panoramic (or) tomographic x-rays viewed to identify the presence 
of any septum, to avoid the possibility of coinciding with “Sinu-
drillTM” placement.  
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• The correct bucco-lingual inclination was determined to avoid the 
possibility of coinciding with the buccal cortex of the maxilla.  
• The face and surgical site were wiped with Povidone Iodine 
(Betadine) solution.  
• Local anesthesia (2% Lignocaine with 1:80,000 adrenaline) was 
administered to the patient. Posterior and Middle superior alveolar 
nerve block along with Greater palatine nerve block was given. 
• An incision was made palatal to the mid alveolar crest in the 
edentulous area and connected with a sulcular incision  of the 
adjacent teeth.  
• Mucoperiosteal flap was elevated exposing alveolar crest of the 
bone. 
• The implant location on the exposed bone was marked with the 
round bur used to form initial breakthrough of bony cortex. 
• A "2mm twist drill" in the bone has to advanced to ‘1-2mm’ short of 
maxillary sinus membrane.wherever needed, depth gauge was used to 
check the orientation and depth of the  prepared site by means of 
RVG. 
• The osteotomy site was further enlarged with the "3.2mm"Sinu-
startTMDrill" along the same length of the opening created by the 
"2mmdrill" 
• The "Sinu-DrillTM" was advanced into the prepared opening using 
the white wheel until the cutting blade is pushed into the                   
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"Sinu-DrillTM". This engages the green wheel. Once it engaged by 
repeated applying the torque on the green wheel in clockwise 
direction upto 3/4th of full turn, followed by 50-100degrees in 
counterclockwise direction the  Sinu-DrillTM has been advanced  until 
the cutting blade reaches the sinus membrane and  it had confirmed 
by the releasing of green wheel after that green wheel got disengaged 
and rotated freely.  
• By turning the white wheel in a counter clock wise direction the 
"Sinu-DrillTM" was removed   
•  The Sinus membrane was elevated gently by first using "3.0 mm" 
curette making sure the tip of the curette was in contact with the 
bone to avoid membrane rupture & then further elevation was done 
with the "4.2 mm" curette with a flexible tip and guided by ‘color 
markings’ present on the curette till the desired membrane elevation 
was obtained. 
• The space which was created between the maxillary alveolar process 
and the new sinus floor was filled incrementally with 
"Cerasorb®M",(a pure-phase (>99%) synthetic β-TCP) sized 500-
1000 µm (65% porosity (Curasan AG GmbH, Kleinostheim, 
Germany) mixed  with "PRP" by the help of "Graft material packer" ,  
meticulously condensed and adapted to the bony walls with "Graft 
material packer". 
•  After the sinus floor augmentation procedure was completed, the 
 
Materials and Methods 
35 
 
mucoperiosteal flap was repositioned and closed over the osteotomy 
site using simple interrupted  sutures technique with 3-0 black silk 
sutures. 
  After surgery, antibiotics were prescribed for 7 days 
(Amoxycillin,500 mg three times per day). Anti inflammatory analgesics 
were prescribed for 5 days .The patient was also instructed to rinse twice 
daily with 0.12% chlorhexidine gluconate mouth rinse for two weeks from 
the second day after surgery to reduce the risk of infection. Patients were 
also instructed to avoid wearing their removable prosthesis and to refrain 
from blowing their nose for one month, to avoid sneezing or coughing and 
to ensure that the surgical site remained undisturbed during the initial stages 
of healing. Patients were advised to follow a soft diet and careful 
maintenance during their routine brushing. 
 
POST-OPERATIVE ASSESSMENT: 
• Clinical evaluation done 2- days post operatively. 
• Patients were examined one week later and sutures removed. The grafted 
sinus was left to heal for 6 months. 
• Patient was recalled for review by 1st, 2nd, 3rd and 6th month. Intraoral 
periapical radiographs and panaromic radiographs were taken.  
• After 6 months, postoperative assessment (OPG & CT Scan) for the gain 
in  vertical bone height, bone volume and bone density were done. 
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 Bone volume & Bone density of ‘Native bone’ pre-operatively, ‘Grafted 
bone’ & ‘Native - Grafted bone’ post-operatively (6thmonth) was measured by C T 
scan using ‘ORS Visual’, a software-based Picture Archiving and Communication 
System (PACS) (Object Research Systems Inc, Montreal, Canada ) . 
 Bone volume & Bone density of ‘Native bone’, pre-operatively were 
measured at the point (Point A/B/C) where it was supposed to be augmented. On 
the other hand post-operatively, ‘Grafted bone’ was measured only at the grafted 
site (β TCP mixed with PRP), whereas, ‘Native & Grafted bone’ was measured at 
the peripheral part of the grafted bone region along with adjacent part of the native 
bone.  
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ARMAMENTARIUM 
DIAGNOSTIC INSTRUMENTS 
1. Mouth mirrors. 
2. Graduated william’s probe (Equinox). 
3. Tweezers 
4. Metal ball stent. 
 
SURGICAL INSTRUMENTS 
1. 2ml Disposable syringe (Unolock) 
2. 2%Lignocaine Hydrochloride with 1:80,000 adrenaline. 
3. Bard parker handle No. 3 
4. Bard parker blade No. 15 
5. Periosteal elevator (Goldmannfox) 
6. Austin Cheek retractor 
7. Curved goldmannfox scissors 
8. Needle holder 
9. Suture cutting scissor 
10. Sterile Test tubes -2 
11. Tissue forceps 
12. Kidney tray 
13. Stainless steel bowl - 2 
14. 3-0 mersilk non-absorbable sutures 
 
Materials and Methods 
38 
 
15. 20ml saline (irrigation) syringes 
16. Normal physiological saline (0.9%w/v) 
17. Round surgical bur 
18. Pilot drill bur (2.0mm) 
19. Contra angle hand piece 
20. Metal suction tip 
21. β- Tricalcium phosphate (Cerasorb® M) 
22. 10% Calcium gluconate 
23. Haemocoagulase (Botropase) 
24. Bone graft carrier 
25. Physio dispenser 
26. 0.2% chlorhexidine mouth rinse 
27. Povidine-iodine solution. 
28. Sinu -Lift™ system disposable kit comprised of 
A.   Sinu-DrillTM                                      
B. 3mm Diameter Curette                   
C. 4.2mm Diameter Curette 
D. Bone packer         
E. Multi Function Handle.                          
F. 3.2mm(Calibrated) Sinu-StartTM drill    
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RAGAS DENTAL COLLEGE AND HOSPITAL 
DEPARTMENT OF PERIODONTICS 
 
 
PROFORMA 
 
OPD NO.: 
 
Name : 
 
Age/ sex : 
 
Address : 
 
Contact no. : 
 
Marital status : 
 
Occupation : 
 
Chief complaint : 
 
History of present illness : 
 
Past Dental history : 
 
Past Medical history : 
 
Family history : 
 
Personal history & Habits : 
 
 
CLINICAL EXAMINATION 
 
Extra oral : 
 
Intra oral : 
 
Missing tooth : 
 
 
 
RADIOGRAPHS 
         IOPA 
         OPG 
         CT SCAN 
BLOOD INVESTIGATION  
 
 Total leucocyte count (TLC) :  
 
            Differential leucocyte count(DLC) :    
                                      
 RBC: 
 Hb%  : 
 E.S.R :                                
 Platelet Count: 
 Blood Sugar :     Random: 
               Fasting: 
                                                Post-Prandial : 
 
 Bleeding Time:                        
 Clotting Time: 
 
  
TREATMENT PLAN : 
 
 
SINUS LIFT SURGERY RELATED TO  : 
 
 
C T  SCAN & OPG MEASUREMENTS  OF BONE HEIGHT.(mm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C T  SCAN  MEASUREMENTS  FOR BONE VOLUME (mm3)& BONE DENSITY(HU): 
 
 
Point 
CT SCAN OPG
Pre-operative Post-operative Pre-operative Post-operative 
A     
B     
C     
PRE-OPERATIVE POST-OPERATIVE (6th Month) 
Native Bone(N.B) Grafted Bone(G.B) N.B & G.B 
Bone 
Volume 
Bone 
Density 
Bone 
Volume 
Bone 
Density 
Bone 
Volume 
Bone 
Density 
            
                
INFORMED PATIENT CONSENT 
 
DEPARTMENT OF PERIODONTICS 
RAGAS DENTAL COLLEGE &HOSPITAL 
UTHANDI, CHENNAI-119. 
 
 
Patient Name: 
 
 
  I have been explained about the nature& purpose of the study in which, I 
have been asked to participate.  I understand that I am free to withdraw my 
consent and discontinue at any time without prejudice to me or affect on my 
treatment.  
 
             I have no objection for undergoing the treatment if treatment shows no 
anticipated results, agree to undergo a suitable or alternative method for the same. 
I have also given the consent for the photographs to be taken at the beginning, 
during and end of the study.  I have agreed to participate in this study. 
 
                                                                                                                                                                  
 
        Signature of the patient 
Station: 
Date:                                                                                                          
 
 
Witness: 
1. 
 
2. 
 
 I will be inspecting and instructing the lab technician to dispose “Bio-
waste” as per universal norms and the sterilization of the glass and the other 
containers used for the particular patient. 
 
 
Signature of P.G Student    Signature of the H.O.D 
  
                
INFORMED PATIENT CONSENT
DEPARTMENT OF PERIODONTICS 
RAGAS DENTAL COLLEGE &HOSPITAL 
UTHANDI, CHENNAI-119. 
Patient Name: 
  I have been explained about the nature& purpose of the study in which, I 
have been asked to participate.  I understand that I am free to withdraw my 
consent and discontinue at any time without prejudice to me or affect on my 
treatment.  
             I have no objection for undergoing the treatment if treatment shows no 
anticipated results, agree to undergo a suitable or alternative method for the same. 
I have also given the consent for the photographs to be taken at the beginning, 
during and end of the study.  I have agreed to participate in this study. 
                                                                                                                                                                  
        Signature of the patient 
Station: 
Date:                                                                                                          
Witness:
1.
2.
 I will be inspecting and instructing the lab technician to dispose “Bio-
waste” as per universal norms and the sterilization of the glass and the other 
containers used for the particular patient. 
Signature of P.G Student    Signature of the H.O.D 
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PREPARATION OF “PRP” 
                                       
       Fig. 1a: Drawing of Venous blood         Fig.1b: Blood with 10% Trisodium Citrate 
 
              
       Fig. 1c:Centrifugation of Blood  Fig.1d:Centrifuged Blood with Plasma at  
                    top & RBC at bottom 
                 
      Fig.1e: ‘PPP’ at the Top,      Fig.1f: Platelet Rich Plasma (PRP) 
 ‘PRP’ in the middle                                                   
         &‘RBC’ at the bottom                      
 
 
 
 
     Fig.2a:
 
 
 
  Fig
 
SI
Pre-operative
.2c :crestal in
NUS AUGM
 UTIL
US
 view (Buccal
cision given  
ENTATIO
IZING ß-T
ING “SINU
       
 view)            
       
                      
N  SURGI
CP MIXED
-LIFTTM S
                
                     F
          
               Fig.2
CAL PROC
 WITH PR
YSTEM”  
ig.2b: Pre-op
d:After muco
EDURE 
P 
               
erative view (
perioosteal fl
occlusal view
ap elevation
 
)                      
                      
             
   
 
 
       Fig.2e
                 
 
   
  F
    
 
    
        Fig.2
    
: Initial osteo
       2mmtwist
ig.2g: Advan
    in prepared
i: Separating
         “4.2mm
tomy prepar
 drill              
cing “Sinu-Dr
 osteotomy   
 the membra
 curette”        
 
ed  with 
                       
    
illTM”           
                       
   
ne further     
                       
               
        
                       
 
                
     Fig
                       
                  
                       
                       
Fig.2f :  Repe
            “Sinu-
.2h: Separat
                  “3m
Fig.2j: Osteo
             memb
ating prior st
StartTMDrill”
ing the sinus 
m curette” 
tomy site afte
rane elevatio
ep with  
        
membrane wi
r sinus with 
n 
        
              
th                  
             
         
                
             
 
 
 
                  
               F
  
                 
 
   
    
        Fig.2
 
 
    
     Fig.2o
                 
 
   
ig.2k: Freshl
 
                       
m:  Mixture 
: Graft filling
               eleva
y prepared “P
  
                       
of β-TCP with
 in space crea
tion                
                       
RP”             
             
                       
   
 PRP             
    
ted after 
                       
              
                    F
                       
                      
                 
                   Fi
 
               
  Fig.
                       
ig.2l: “ PRP”
     ‘ 1 ml of  H
& ‘1 ml of 10
g.2n: Gel like
   β-TCP&
2p: Using “B
               graf
 mixing  with
aemocoagula
%  Calcium G
 consistency 
 PRP mixtur
one Packer” f
t condensing 
  
se’   
luconate  
after 30 sec.  
e                     
or membrane
 
 
            
              
                 
        
 
 
  
Fig.2q: Af
 
 
   Fig.2s: 
                 
 
 
 
 Fig.2u: P
                 
                 
ter desired sin
Post-operativ
     (Buccal vie
ost-operative
  (Buccal view
    
us floor eleva
e view after 1
w)                  
 view after 6 m
)                  
     
tion  with gr
       
 week             
                       
      
onths           
                
aft           Fig.
 
               
                    F
                       
               
               Fig.2
 
2r: Mucoperi
 su
ig.2t:  Post-op
              (Occl
v: Post-opera
           (oc
osteal flap ap
tures  
erative view 
usal view)      
tive view afte
clusal view)   
proximated w
after 1 week 
                      
r 6 months  
    
 
ith  
 
                       
                     
                
                
 
 
 
                 
 
     
         Fig.3
                 
 
    
Fig.3e: Ad
                 
 
    Fig.3a: Pre
c: Advancing
  1-1.5mm sho
vancing “Sin
       osteotomy
-operative      
 “Sinu-StartT
rt of the sinu
u-DrillTM” pr
 site       
SURGIC
(‘RV
                      
  
MDrill”till      
s  
   
epared in 
AL PROCE
G’ IMAGE
                 
                  Fig
                   
                      
 
                    
       F
 
DURE  
S) 
. 3b:Verifyin
           Fig.3d 
 “
ig.3f :After si
 “
g depth after 
:Checking de
Sinu-StartTMD
nus membran
Sinu-DrillTM”
2mm twist dr
pth after  
rill” 
e elevation w
 
                 
ill                   
                  
              
ith  
         
      
          
 
 
                
  
Fig.4a: Af
 
   Fig.4c:  
 
     Fig.4e :
 
                     
PO
ter desired sin
After 2ndMon
 6thMonth po
  
ST – OPERA
us floor eleva
th post-opera
st-operatively
TIVE  VIE
     
tion  with gra
       
tively            
 
 
WS  IN  SUB
            
ft              Fig
               
                Fig.
SEQUENT
.4b: After 1st
4d: After 3rd
  MONTHS 
Month post-o
Month post-o
 
peratively 
 
peratively 
 
 
 
 
               
Circle rep
                   
resents “gr
                   
afted” site. 
Fig.5a: Pr
     Fig.5b: P
e-operative
            
ost-operat
 O.P.G  
                   
ive O.P.G (
                   
Immediate)
           
 
 
 
 
 
               
     
Circle rep
                   
                   
resents “au
                   
              Fig
gmented” s
    Fig.5c: P
.5d: Post-o
ite. 
ost-operati
 
perative O.
ve O.P.G (A
P.G (At 6th
fter 2 mon
Month) 
ths) 
 
 
BONE 
 
Estimatio
 F
Red color 
Estimatio
 F
Green colo
Estimatio
    
Green colo
Red color 
DENSITY 
n of Bone V
ig.6a  
represent nativ
n of Bone V
ig.6d  
r represents  a
n of Bone V
 Fig.6g 
r represents  a
represent integ
& VOLUM
olume & De
    
  
e bone.  
olume & De
    
  
 grafted bone
olume & De
    
  
 grafted bone
ration region
E MEASU
nsity of “Nat
       Fig.
nsity of “On
       Fig.
 region.  
nsity of “Nat
         Fig
 region.  
 between  graf
REMENTS
ive Bone”(P
6b 
ly Grafted B
6e 
ive & Graft
.6h 
ted bone and 
 (USING C
re-operative
    
 
one” (6th Mo
    
 
ed Bone” (6t
    
 
native bone. 
T Scan & O
)  : 
  Fig.6
nth Post-op
  Fig.6f
h Month Pos
  Fig.6
RS Softwa
c 
erative) : 
 
t-operative) 
i 
re) 
 
 
: 
 
   
 
   
   
   
 
   
   
 
 
 
 
 
 
SINUS AUG
                7a
 
   7c. After m
                     
 
     7e.Advan
   prep
MENTATIO
.Pre-operative
ucoperioste
                    
cing “Sinu-D
ared osteoto
N AND IM
 view             
al flap eleva
                     
rillTM” in  
my               
PLANT PLA
           
                      
        
tion        7d. 
                     
            
                7f.S
                     
CEMENT 
     7b.After cr
Osteotomy s
    “Sinu-star
eparating th
       with “3m
AFTER 6 M
estal incision
ite prepared
tTM Drill” 
e sinus mem
m curette”
ONTHS 
 
 
 with   
  
brane         
 
  
7g
   
 
   
 
 
 
 
.Separating
             “4.2
   7i. Mucop
    with
7k.Cr
 
 the sinus m
mm curette”
eriosteal flap
 sutures      
estal incision
  
embrane wit
                     
   
 closure       
                     
  
  
 
          
h                 7
                    
               
                    
                     
                 
      7
 
h.Using “Bo
         graft C
     7j.Post-o
           (After
l. Preparatio
          usi
ne Packer” 
ondensation
perative view
 6 Months) 
n of the imp
ng drill 
   
for           
   
    
                   
lant site  
                             
   
   
   
 
   
   
   
   
   
   
  
 
 
 
 
 
 7m. “Nobel B
                      (
   7o.Properly
                    
  
   7q.  3.5 x 1
                    
iocare Replac
4.3.×10mm)  
 oriented & s
0 mm impla
region of 25 
e select impla
                       
tabilized imp
nt placed in 
                     
           
nt”             7n
                       
              
lant             7
         
the         7r.M
                     
.  After impla
         Osteotom
p.After cove
ucoperiost
                  w
nt placement 
y site. 
r screw plac
eal flap appr
ith suture 
 
 in            
ement 
 
oximated  
 
 
   
   
   
 
 
   
 
   
 
  Post-opera
        
                     
   
   
tive after 6m
                    
RV
 
onths           
                     
G IMAGES
          
                  A
               
fter implant placement 
 
 
Results 
 
40 
 
RESULTS 
 This study assessed the gain in vertical height, bone volume & bone 
density  of the alveolar ridge of the maxillary alveolar crest following sinus floor 
augmentation using bone substitute i.e., β-Tricalcium phosphate (Cerasorb® M) 
with autologous Platelet rich plasma (PRP).Clinical and radiographical assessment 
were carried out with the aid of OPG & CT Scan . Post – operative morbidity was 
also assessed.           
Clincal Observations: 
           Clinically, No complications were observed during or after the surgical 
procedure. All patients healed uneventfully, and no signs and symptoms of 
maxillary sinus related disease were observed during the six months period 
following surgery.  
Radiographic Observations: 
 When compared to the baseline, the 6 months post-operative radiographic 
(OPG, IOPA & Computerized tomography) examination showed new tissue 
obtained after sinus lifting and grafting procedures. There was an increased bone 
height with progressive resorption of the grafted bone substitute, which was 
confirmed by assessing the Bone Density & Bone Volume using ORS software. 
The radiographic data of each patient are represented in Tables from 1 to 3. 
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STATISTICAL ANALYSIS 
 The radiographic data from each group were statistically analyzed using 
SPSS Version 16.0 software represented in Tables from 4 to 12. Correlation 
between the pre-operative and post-operative were calculated by Wilcoxson 
signed rank sum Test.  
I. OPG Bone height measurement (mm) : (Table 5 & 9) 
        A).Bone Height measurement At Point-A ;  
The Mean bone height pre-operatively measured was 7.50mm ±1.35. The 
mean increase was 2.80mm after 6 months as the mean post-operative values 
measured 10.30mm±1.78 which was statistically significant p < 0.01  
(0.007). 
       B). Bone Height measurement At Point-B ;  
 At this point, the mean post-operative measurement after 6 months showed 
an increase to 10.10mm±2.67 when compared to the mean pre-operative 
levels 6.85mm±0.78. So, the mean increase was 3.25mm which was 
statistically significant. p < 0.01 (0.005) 
 C). Bone Height measurement At Point-C ;  
 Though there was a noticeable increase between the pre-op.and post-op. 
values at the both points A & B than Point-C which was slightly less with 
mean post-operative values being 8.40mm±2.38 as against mean pre-
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operative values 7.30mm±1.25 but, mean increase was 1.10mm which was 
slightly statistically significant. p < 0.05 (0.027). 
II. C T Scan Bone height measurement (mm) : (Table 4 & 9) 
 A). Bone Height measurement At Point-A ;  
 Mean post-operative values (at the end of study period – 6 months) showed 
a marked increase of 9.07mm±1.79 as compared to the mean pre-operative 
values 6.22mm±1.30. So, there was a mean increase of 2.85mm.This was 
statistically significant. p < 0.01 (0.005) 
 B).Bone Height measurement At Point-B ; 
 Mean post-operative values (at the end of study period – 6 months) 
 similarly recorded an increase of 8.70mm±2.74 when compared to the 
 pre-operative values 5.53mm±0.72. Here, there was a mean increase of 
 3.17mm. This was also statistically significant. p < 0.01 (0.005) 
 C).Bone Height measurement At Point-C ; 
    Though in accordance with the above trend, mean post-operative values 
 7.22mm±2.16 showed only a slight mean increase of 1.19mm from the 
 pre-operative values 6.03mm±1.07.  This was slightly statistically less 
 significant. p < 0.01 (0.009). 
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RESULTS RELATED TO “DESIRED AREA OF SINUS AUGMENTATION” 
ONLY :- (Table 6 & 10)                       
 Even though statistically significant values were recorded in relation to the 
above said parameters namely bone height measurements at point A(or)B(or)C , 
some sites displayed less significant difference which may be attributed to the 
technique followed. However it was quite evident that the augmented site 
definitely showed a favorable increase in height, thereby pivoting the 
predictability of this technique in achieving maximum augmentation with minimal 
invasion 
 III.OPG Bone height measurement (mm) : 
 At the desired area of the sinus augmented site irrespective of reference 
points, the mean bone height pre-operatively measured 7.05mm ±1.09. the mean 
increase was 4.45mm after 6 months as the mean post-operative values measured 
11.50mm±1.68 which was more statistically significant. p < 0.01 (0.004). 
IV.C T Scan Bone height measurement (mm) : 
 Similarly as above said OPG Measurements, there was a noticeable 
increase between the pre-op.and post-op. mean values being the Mean post-
operative values (at the end of study period – 6 months) recorded an increase 
10.20mm±1.68 when compared to the pre-operative values 5.80mm±0.98.Here, 
there was a mean increase of 4.40mm. This was also more statistically significant. 
p < 0.01 (0.005). 
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 Thus the mean bone height attained post-operatively as  measured in OPG 
(4.45mm) and CT scan (4.40mm) were statistically highly significant p < 0.01. 
V. Comparing CT Scan Bone Volume (mm3): (Table 7,8,11 & 12) 
 While comparing the mean bone volume. it was noticed that ‘Grafted 
Bone’(98.90mm3±54.08)and‘Native&Grafted Bone’(229.47mm3±114.53)recorded 
a higher volume of bone when compared to the ‘Native Bone(’60.32mm3±14.39). 
This was statistically significant p < 0.01 (0.005).  
VI. Comparing CT Scan Bone Density (HU): (Table 7,8,11 & 12) 
 The  Mean bone density  of  ‘Grafted  Bone’ site(537.59HU±148.97) was 
higher when compared to ‘Native Bone’ site (378HU±90.27), which was 
statistically significant p < 0.01 (0.009) .‘Native & Grafted Bone’ site 
(490.49HU±112.18) measured higher when compared to ‘Native Bone’ 
site(378HU±90.27) which was  statistically less significant p < 0.05 (0.028).  
           These data demonstrate an increase in the bone parameters i.e bone height, 
bone volume and bone density with statistically significant values.   
MEASUREMENTS OF BONE HEIGHT USING CT SCAN & OPG, 
BONE VOLUME & BONE DENSITY USING CT SCAN 
 
 Table No. 01. 
 
C T  SCAN & OPG MEASUREMENTS  OF BONE HEGHT (mm) - AT 3 REFERENCE 
POINTS: 
 
REFERENCE OPG (mm) CT SCAN (mm)
CASE No. POINTS Pre-op. Post-op. Pre-op. Post-op.
No.1 A 8 9.5 6.4 7.73 
  
B 7.5 12 5.91 10.35 
C 9 10 7.39 8.22 
No.2 A 7.5 10.5 5.89 8.83 
  
B 7 12 5.51 10.18 
C 8.5 10.5 7.22 9.28 
No.3 A 9 9.5 8.1 8.4 
  
B 7.5 12 6.42 11.02 
C 7.5 7.5 6.29 6.5 
No.4 A 8 8 6.75 6.79 
  
B 8 14 6.91 13.12 
C 7.5 7.5 6.59 6.54 
No.5 A 7 10 5.3 9.56 
  
B 6.5 10.5 4.79 8.8 
C 7 10 5.43 9.31 
No.6 A 6.5 11 5.08 9.59 
  
B 6.5 7 5.09 5.4 
C 7 7.5 5.39 5.81 
No.7 A 7 11.5 5.5 9.98 
  
B 6.5 7 5.12 5.41 
C 6 6 4.87 4.9 
No.8 A 9 13 7.68 11.8 
  
B 7.5 12 5.81 10.19 
C 9 13 7.39 11.21 
No.9 A 8.5 12.5 7.5 11.5 
  
B 6 8.5 4.78 7.09 
C 6 6.5 4.89 5.21 
No.10 A 4.5 7.5 4.01 6.49 
  
B 5.5 6 4.98 5.39 
C 5.5 5.5 4.84 5.19 
 
 
 
 
 
 
 
 
 
Table No. 02. 
 
 C T SCAN & OPG MEASUREMENTOF BONE HEIGHT (mm) : 
 
  AT THE “DESIRED AREA OF THE SINUS AUGMENTATION” FOR 10 PATIENTS: 
 
  BONE HEIGHT IN CT 
SCAN 
BONE HEIGHT IN OPG 
CASE No. REFERENCE POINT Pre-op.(mm) Post-op.(mm) Pre-op.(mm) Post-op.(mm)
No.1 B 5.91 10.35 7.5 12 
No.2 B 5.51 10.18 7 12 
No.3 B 6.42 11.02 7.5 12 
No.4 B 6.91 13.12 8 14 
No.5 A 5.3 9.56 6.5 10.5 
No.6 A 5.08 9.59 6.5 11 
No.7 A 5.5 9.98 7 11.5 
No.8 B 5.81 10.19 7.5 12 
No.9 A 7.5 11.5 8.5 12.5 
No.10 A 4.01 6.49 4.5 7.5 
 
 
Table No. 03. 
 
CT SCAN MEASUREMENTS  FOR BONE VOLUME (mm3) & BONE DENSITY (HU) 
 
  AT THE “DESIRED AREA OF THE SINUS AUGMENTATION” FOR 10 PATIENTS: 
 
CASE 
No. 
PRE-OPERATIVE POST-OPERATIVE (6th Month) 
Native Bone(N.B) Grafted Bone(G.B) N.B & G.B 
Bone 
Volume(mm3) 
Bone 
Density(HU) 
Bone 
Volume(mm3) 
Bone 
Density(HU) 
Bone 
Volume(mm3) 
Bone 
Density(HU) 
No.1 67.34 377.31 141.75 810.75 300.34 645.28 
No.2 62.16 319.48 92.07 546.29 244.29 548.73 
No.3 62.79 300.81 73.4 706.12 406.12 505.93 
No.4 82.64 398.33 233.82 601.51 390.3 371.92 
No.5 71.68 484 90.92 553.13 136.14 587.78 
No.6 47.42 527.92 91.33 534.75 161.91 488.66 
No.7 55.56 309.07 84.92 509.55 123.41 533.46 
No.8 58.75 472.14 68.62 437.01 273.63 566.47 
No.9 65.47 331.8 74.59 370.3 197.18 297.3 
No.10 29.34 259.33 37.54 306.48 61.44 359.34 
 
COMPARISION OF PRE-OPERATIVE & POST-OPERATIVE MEAN 
BONE HEIGHT AT  3 REFERENCE POINTS USING C T SCAN – 
Wilcoxon Signed Rank Sum Test 
 
Table No. 04 
Parameters Pre – Operative (mm) Post – Operative (mm) P- value
Ref.- Point n Mean SD n Mean SD  
A 10 6.22 1.30 10 9.07 1.79 0.005** 
B 10 5.53 0.72 10 8.70 2.74 0.005** 
C 10 6.03 1.07 10 7.22 2.16 0.009** 
 
*denotes significance at 5% level 
**denotes significance at 1% level 
 
COMPARISION OF PRE-OPERATIVE & POST-OPERATIVE MEAN 
BONE HEIGHT AT  3 REFERENCE POINTS USING OPG –              
Wilcoxon Signed Rank Sum Test 
 
Table No. 05 
Parameters Pre – Operative (mm) Post – Operative (mm) P- value
Ref.- Point n Mean SD n Mean SD  
A 10 7.50 1.35 10 10.30 1.78 0.007** 
B 10 06.85 0.78 10 10.10 2.67 0.005** 
C 10 07.30 1.25 10 08.40 2.38 0.027* 
*denotes significance at 5% level 
**denotes significance at 1% level 
 
 
 
COMPARISION OF PRE-OPERATIVE & POST-OPERATIVE MEAN 
BONE HEIGHT ONLY AT THE DESIRED AREA OF THE  SINUS 
AUGMENTATION FOR 10 PATIENTS  USING   C T SCAN & OPG –   
Wilcoxon Signed Rank Sum Test 
 
Table No. 06 
  
n 
Pre-operative Post-operative 
p-value       Mean        S.D      Mean        S.D 
Bone Height (C T Scan)  10 5.80 0.98 10.20 1.68 0.005**
 Bone Height (OPG)        10 7.05 1.09 11.50 1.68 0.004**
 
*denotes significance at 5% level 
**denotes significance at 1% level 
 
  
COMPARISION OF PRE-OPERATIVE(Native Bone) & POST-
OPERATIVE(Grafted Bone) MEAN OF BONE VOLUME & BONE 
DENSITY USING C T SCAN AT THE AUGMENTED SITE 
 
Table No. 07 
         pre-op. (Native Bone) Post-op.(Grafted bone)   
 n      Mean      S.D      Mean  S.D p-value
Bone 
Volume(mm3) 10 60.32 14.39 98.90 54.08 0.005**
Bone Density 
(HU) 10 378.02 90.27 537.59 148.97 0.009**
 
 
*denotes significance at 5% level 
**denotes significance at 1% level 
 
 
 
COMPARISION OF PRE-OPERATIVE (Native Bone) & POST-
OPERATIVE (Native bone and Grafted Bone) MEAN OF BONE VOLUME 
& BONE DENSITY USING C T SCAN AT THE AUGMENTED SITE 
 
Table No.08 
         pre-op. (Native Bone) Post-op.(N.B & G.B)   
 n      Mean      S.D      Mean  S.D p-value
Bone 
Volume(mm3) 10 60.32 14.39 229.48 114.53 0.005**
Bone Density 
(HU) 10 378.02 90.27 490.49 112.18 0.028* 
 
*denotes significance at 5% level 
**denotes significance at 1% level 
 
 
 
  
INTERPRETATION OF STATISTICAL ANALYSIS 
 
 
 
MEAN OF ACHIEVED BONE HEIGHT AT 3 REFERENCE POINTS;             
(Table No. 09) 
 Point - A Point - B Point -C 
Bone Height (C T Scan)  2.85mm 3.17mm 1.19mm 
Bone Height (OPG)  2.80mm 3.25mm 1.10mm 
 
 
 
 
MEAN OF ACHIEVED BONE HEIGHT (ONLY AT THE DESIRED AREA 
OF AUGMENTATION);  
(Table No. 10) 
 Bone Height (C T Scan)  4.40 mm
Bone Height (OPG)  4.45 mm
 
 
 
 
MEAN OF ACHIEVED BONE VOLUME & BONE DENSITY  
      - (Native Bone - Grafted Bone); (Table No. 11) 
Bone volume (C T Scan)  38.58 mm3 
Bone Density (C T Scan)  159.57 HU
 
 
 
 
MEAN OF ACHIEVED BONE VOLUME & BONE DENSITY 
     - (Native Bone - Native & Grafted Bone); (Table No. 12) 
Bone volume (C T Scan)  169.16 mm3 
Bone Density (C T Scan)  112.47 HU
 
COMPARISION OF PRE-OPERATIVE & POST-OPERATIVE MEAN 
BONE HEIGHT AT  3 REFERENCE POINTS USING C T SCAN – 
Wilcoxon Signed Rank Sum Test 
Table No. 04 
Parameters Pre – Operative (mm) Post – Operative (mm) P- value
Ref.- Point n Mean SD n Mean SD
A 10 6.22 1.30 10 9.07 1.79 0.005** 
B 10 5.53 0.72 10 8.70 2.74 0.005** 
C 10 6.03 1.07 10 7.22 2.16 0.009** 
*denotes significance at 5% level 
**denotes significance at 1% level 
COMPARISION OF PRE-OPERATIVE & POST-OPERATIVE MEAN 
BONE HEIGHT AT  3 REFERENCE POINTS USING OPG –              
Wilcoxon Signed Rank Sum Test 
Table No. 05 
Parameters Pre – Operative (mm) Post – Operative (mm) P- value
Ref.- Point n Mean SD n Mean SD
A 10 7.50 1.35 10 10.30 1.78 0.007** 
B 10 06.85 0.78 10 10.10 2.67 0.005** 
C 10 07.30 1.25 10 08.40 2.38 0.027* 
*denotes significance at 5% level 
**denotes significance at 1% level 
COMPARISION OF PRE-OPERATIVE & POST-OPERATIVE MEAN 
BONE HEIGHT ONLY AT THE DESIRED AREA OF THE SINUS
AUGMENTATION FOR 10 PATIENTS USING   C T SCAN & OPG – 
Wilcoxon Signed Rank Sum Test
Table No. 06 
n
Pre-operative Post-operative 
p-value     Mean        S.D      Mean        S.D 
Bone Height (C T Scan)  10 5.80 0.98 10.20 1.68 0.005**
 Bone Height (OPG)        10 7.05 1.09 11.50 1.68 0.004**
*denotes significance at 5% level 
**denotes significance at 1% level 
COMPARISION OF PRE-OPERATIVE(Native Bone) & POST-
OPERATIVE(Grafted Bone) MEAN OF BONE VOLUME & BONE 
DENSITY USING C T SCAN AT THE AUGMENTED SITE
Table No. 07 
      pre-op. (Native Bone) Post-op.(Grafted bone) 
 n      Mean      S.D      Mean  S.D p-value
Bone
Volume(mm3) 10 60.32 14.39 98.90 54.08 0.005**
Bone Density 
(HU) 10 378.02 90.27 537.59 148.97 0.009**
*denotes significance at 5% level 
**denotes significance at 1% level 
COMPARISION OF PRE-OPERATIVE (Native Bone) & POST-
OPERATIVE (Native bone and Grafted Bone) MEAN OF BONE VOLUME 
& BONE DENSITY USING C T SCAN AT THE AUGMENTED SITE 
Table No.08 
      pre-op. (Native Bone) Post-op.(N.B & G.B) 
 n      Mean      S.D      Mean  S.D p-value
Bone
Volume(mm3) 10 60.32 14.39 229.48 114.53 0.005**
Bone Density 
(HU) 10 378.02 90.27 490.49 112.18 0.028* 
*denotes significance at 5% level 
**denotes significance at 1% level 
INTERPRETATION OF STATISTICAL ANALYSIS
MEAN OF ACHIEVED BONE HEIGHT AT 3 REFERENCE POINTS;             
(Table No. 09)
Point - A Point - B Point -C 
Bone Height (C T Scan)  2.85mm 3.17mm 1.19mm 
Bone Height (OPG)  2.80mm 3.25mm 1.10mm 
MEAN OF ACHIEVED BONE HEIGHT (ONLY AT THE DESIRED AREA 
OF AUGMENTATION);  
(Table No. 10)
 Bone Height (C T Scan)  4.40 mm
Bone Height (OPG)  4.45 mm
MEAN OF ACHIEVED BONE VOLUME & BONE DENSITY  
      - (Native Bone - Grafted Bone); (Table No. 11)
Bone volume (C T Scan)  38.58 mm3
Bone Density (C T Scan)  159.57 HU
MEAN OF ACHIEVED BONE VOLUME & BONE DENSITY 
     - (Native Bone - Native & Grafted Bone); (Table No. 12)
Bone volume (C T Scan)  169.16 mm3
Bone Density (C T Scan)  112.47 HU
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DISCUSSION 
Maxillary sinus augmentation surgical techniques as well as the 
osteoconductive potential of various bone substitutes have evolved greatly 
allowing the predictable and successful placement of dental implants in the 
atrophic posterior maxillary region13,143,2 .Several studies have reported excellent 
long term survival rates for implants placed in the augmented maxillary 
sinuses12,139,59,133  
The most commonly used approach, the lateral window technique had 
potential complications include tearing of the membrane, bleeding, infection, and 
sinus obstruction149.This technique requires considerable surgical skill and time 
and also often giving rise to unpleasant sequelae such edema and discomfort. A 
less invasive alternative was introduced by Summers known  as  the  osteotome  
or  bone-added osteotome sinus-floor elevation (BAOSFE) technique, it  has  been 
shown  to yield only a modest increment in bone height of only 3±0.8 mm98. 
Membrane  perforation  and  tears, benign paroxysmal positional vertigo 105,45,108 
are  also added complications. So, current trend centers around the development of 
minimally invasive techniques, which are designed to minimize post-operative 
morbidity, while concurrently achieving maximal augmentation. 
As the single stage technique was beset with major drawbacks associated 
with implant stability and parallelism,65 and a host of technical problems and 
complications such as releasing the mount from the implant (10.2%), causing the 
dislocation of the implant from its original implantation axis and bone fractures 
between the sinus augmentation window and osteotomy site (3.4%) ultimately 
jeopardizing implant success83, the 2 stage delayed approach was planned. Here, 
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the initial bone height was less than 5-6mm necessitating graft incorporation  The 
first step was  the sinus membrane elevation followed by  grafting, which requires 
a longer time to be revascularized and integrated. The second step is the implant 
placement several months later ,as this promoted an immediate healing response 
similar to that of viable bone.  
The maxillary sinus floor seems to be ideally suited for the use of various 
bone substitutes because of its high osteo-regenerative potential. The quantity and 
quality of the host bone are crucial for the stability of implants placed in the 
alveolar ridge. Bone graft augmentation is a commonly used in an effort to 
increase the bony support for oral implants13,81,50. Various types of bone 
substitutes have been proposed 17 to provide adequate viable bone to enhance 
osseointegration for successful implant placement.  The use of pure phase of β-
TCP as a synthetic bone substitute material is evenly gaining popularity. 
 
The present study reports a minimally invasive two staged procedure for 
maxillary bone augmentation using the “Sinu-lift systemTM”. Clinical and 
radiographical evaluations were used to assess the results of bone regeneration 
obtained. The study was designed to evaluate the gain in the vertical bone height 
following the sinus augmentation using ‘Pure-phase’ β-TCP (Cerasorb®M) mixed 
with PRP, to assess the bone volume and bone density and also to assess post-
operative morbidity associated with the “Sinu-lift system” 
A comprehensive medical history was obtained and only those patients 
who met all the selection criteria were enrolled for the study. Pre-operative 
assessment and hematological tests were done. The pre-operative assessment of 
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the distance between the alveolar bone crest and the floor of the maxillary sinus 
was done using OPG & CT scan. For assessing bone volume and bone density a 
CT scan was used.  
Panaromic radiographs revealed to the clinician only a gross determination 
of the height of the alveolar ridge and the ability to identify anatomical structures. 
Accurate measurements were difficult with these techniques. The need for cross 
sectional visualization of the alveolar ridge, accurate measurements, and the 
visualization of internal anatomy such the maxillary sinus made the development 
of specific tomographic units for dental implant imaging more immediate-                
Jacobs R.(1999).60                
The height of bone between the alveolar bony crest and the floor of the 
maxillary sinus lining was measured at three reference points. The resident bone 
volume & density was measured as “Native Bone’ volume & density” at the 
reference point related to the site where the augmentation was supposed to be 
have been done. 
Following sinus augmentation, after a period of six months, the increase in 
the bone height obtained between the alveolar bone crest and the floor of the 
maxillary sinus lining was analyzed with the aid of OPG& CT scan. Gains in the 
bone volume and density were observed at the reference point related to grafted 
bone region as “Grafted bone’ volume & density” and “Native& grafted bone’ 
volume and density”, which was the integrated region between the graft and the 
native bone as evaluated with the CT scan. 
While evaluating with the OPG, there was a significant increase in the 
reference point related to the “Grafted bone” than the other two reference points 
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when compared pre-operatively. The mean height at the “Native bone” was found 
to be 7.05mm which increased to 11.50mm. at the end of  6 months. Thus, the 
added bone height was 4.45mm after 6 months.  
The pre-operative and the post-operative measurements were also done 
using CT scan. Here results were similar to that obtained OPG, significant 
increase in the reference point related to the “Grafted bone” than the other two 
reference points when compared pre-operatively. The mean height at the “Native 
bone” was found to be 5.80mm which increased to 10.20mm at the end of 6 
months.. Thus, the added bone height was 4.40mm after 6 months.  
With panoramic X-rays, a preliminary evaluation of bone density only can 
be done, within limitations, on the opacity of bone  structures and on  localizing  
inter-trabecular  spaces. 
              According  to  Misch,  the  most  accurate  imaging  method  for  
exploring  bone  density  is  the Computed Tomography. Based  on  the 
Hounsfield  density  units  (HU)  the  condition  of  the  alveolar  process can be 
appreciated in any region, using the  “spot” tomo-densitometry.  
Computerized tomography is a more objective, non-invasive and reliable 
method offering the best assessment modality for bone morphology and 
qualitative analysis of the residual bone. Bone density and volumetric analysis 
based on Computerized tomography is the best tool for studying bone related 
morphology and capable of determining bone volume and density of the grafts up 
to 97% accuracy.63,137  
 Radiographically, the apical elevation of the sinus floor was observed 
together with the presence of the radioopaque graft material.The  radiological 
 
Discussion 
49 
 
density of the graft material decreased  due to the progressive resorption which 
was observed on subsequent radiographic follow-ups. 
 The Mean Bone Volume of the “Grafted bone” (98.90mm3) was observed 
to be higher than “Native Bone”(60.32mm3) after 6 months post-operatively. The 
Mean Bone Density of the “Grafted bone” was 537.59HU which is higher when 
compared to the “Native Bone” (378.02HU). These results showing increase in 
bone parameters are in accordance with earlier studies done similarly, the sole 
differing attribute being immediate implant placement124,59. 
           A more radioopaque appearance in C T scan and OPG was observed after 6 
months post-operatively revealing that new bone formation (osteogenesis) had 
occurred replacing the graft material because of the osteoconductive nature of the 
graft and addition of PRP which would have accelerated this osteogenic process 
by enriching the bone grafts with the high concentration of growth factors as 
revealed in previous studies.80,85 It could also be attributed to the mineral 
composition of the residual graft material still being in the resorption and 
remodeling process and would probably be replaced by bone subsequently.  
 Cerasorb®M 500-1000 µm was used for the study. Cerasorb®M dental 
ceramic matrix creates a network of large, smoothly interconnected multipores 
(total porosity of approx. 65 vol.%). A ceramic material of this porosity ensures 
optimal resorption to encourage rapid bone regeneration. The material with micro, 
meso- and macropores in a range of 0.1-500 µm supports rapid ossification with 
local bone, thus accelerating the resorption process. It behaves as an 
osteoconductive material. 
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 The focus of analysis was placed on examinations performed within six 
months. It was observed that the radiographic visibility of particles decreased with 
time resulting in a bonelike radiopacity, allowing accurate evaluation of defect 
fill/augmentation in the immediate postoperative period and in the succeeding 
months till the 6th  month study period. Any residues of Cerasorb® M that was 
visible in radiographs preferably indicate an ongoing delayed resorption followed 
by bone formation.  Usually it resolves by a physicochemical process and in sinus 
grafting, Cerasorb M required a waiting period of 6 to 9 months until  implants 
can be placed. Horch HH et al56 This probably indicates that it does not interfere 
with bone remodeling unlike autologous bone grafts or Hydroxyapatite and 
Impure-TCP.112,70  
 Thus, Cerasorb®M, being a non-immunogenic, with interconnected 
porosity, resorbable osteoconductive material provides a predictable basis for 
bone regeneration and can be used in maxillary sinus augmentation as an ideal 
material.  
 The use of bone substitutes become more predictable if they are used in 
combination with PRP.140 Platelet rich plasma (PRP) has the potential to increase 
the rate of bone formation in a graft and to enhance density of the newly formed 
bone because of its “osteoregenerative” potential endowed by the presence of 
growth factor85,80,71 and hence was used in combination with Cerasorb®M here.   
Platelet-derived growth factor initiates connective tissue healing and 
activates bone regeneration, including mitogenesis of preosteoblasts, by increasing 
the number of healing cells, triggering angiogenesis, and activating macrophages. 
TGF-β is a generic growth factor that acts in general connective tissue repair and 
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regeneration and causes differentiation of preosteoblasts to mature osteoblasts ; it 
is also a potent inhibitor of osteoclast formation and bone resorption, favoring 
bone formation.  
The  fibrinogen content of PRP  proves to be an excellent haemostatic tool, 
tissue sealant, wound stabilizer and graft condenser through the creation of a gel 
like substance that allows for sculpting and excellent adherence in defects. 
Hemocoagulase is the enzyme complex based fundamentally on coagulative and 
anti-hemorrhagic properties of those fractions isolated from the poison of 
‘Bothrops atrox’ or ‘Bothrops jararaca’. converts fibrinogen to fibrin through the 
cleavage of the Arg-Gly bonds of the α-chain, resulting in a exclusive release 
fibrinopeptide A from fibrinogen  and promotes the interaction of platelets with 
fibrin clot to coagulate the blood to coagulate the blood52. Haemocoagulase is a 
mixture containing batroxobin and factor X activator. This augment enzyme 
activity in healing phases, including clot formation and clot lyses. 
 Moreover, batroxobin provides mainly slower and controlled release of 
Growth Factors since platelets doesn’t activated during clotting phase 
(Niewiaroswki S et al,198096 & Hantgan RR et al,1985 52) it  accelerates the 
clotting action  of calcium, does not induce any cross reacting antibodies like 
bovine thrombin and it is very cheap when compared to human thrombin. 
 So, these data demonstrating the increase in bone quality and quantity 
(height and density) indicate that  the combination of Cerasorb®M and PRP can 
be used successfully for sinus augmentation procedures.  
No complications were observed either during surgical procedure or after 
the completion of surgery upto 6 months period of this study. None of the patients 
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exhibited sinus pathology following surgery. This was probably the result of a 
meticulous surgical protocol and patient selection and the minimal invasiveness of 
the sinu-lift system.  
           However, as regards the use of “Sinu-liftTM system” there is a dearth of 
literature for accurate reference. 
           Incidences of membrane perforation (11-56%) and post-operative 
morbidity have been reported with the conventional lateral window technique 149. 
Also, recently a systematic review TanWC et al.27 reported incidences of 
membrane perforation ranging from 0% to 21.4% and post-operative infection 
from 0%to 2.5%  after transcrestal SFE by means of various surgical procedures. 
The episodes of ‘BPPV (Benign short recurrent episodes of vertigo) seen in the 
patients who underwent SFE with osteotome technique 105,45,108 as a result has  
made it an obsolete therapy. In this study no such complications were observed 
during or after surgical procedures and  thus the “Sinu-liftTM system” seems to 
score here. 
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SUMMARY & CONCLUSION 
 The study titled “Clinical & radiographic evaluation of sinus floor 
augmentation utilizing β -Tricalcium phosphate(Cerasorb®M) in conjunction 
with Platelet rich plasma using Sinu-liftTM system ”enrolled 10 patients seeking 
posterior maxillary region implant placement, strict measures were observed in 
patient selection followed by an aseptic surgical protocol under local anaesthesia 
using the “sinu-liftTM system” and to enhance bone regeneration using β-
Tricalcium phosphate in combination with platelet rich plasma.                                     
 The study was  evaluated after a 6 months period with bone related 
parameters being assessed at base line,1st month,2nd month, 3rd month and 6th 
month using OPG and while CT scan was  taken at base line and 6th month and the 
results were analyzed.  
 Within the limits of this study, the following conclusions have been 
elucidated:-  
1.) β-Tricalcium phosphate with its osteo-conductive properties can be used as 
a good bone substitute for augmentation of maxillary sinus in atrophic 
maxilla prior to implant placement. 
2.) PRP with its bounty of growth factors serves to enhance the regenerative 
potential of β-Tricalcium phosphate and additionally improves the 
handling properties of the bone graft substitute.  
3.) Bone density and Bone volume were definitely enhanced adding credence 
to the study assessed by radiographic analysis.  
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4.) Post operative morbidity was minimal, thus encouraging the incorporation 
of this method in routine sinus lift procedures. 
5.) The Sinu-liftTM system, is definitely reliable tool in achieving maximum 
sinus lift for augmentation, whole being minimally invasive. Future 
directions should see a more pivotal role to be played by this method of 
sinus lift prior to implant placement. 
 Thus, it is appropriate to conclude that sinus-floor elevation using the 
“sinu-liftTM system” has obvious advantages, paving the way for maximal 
augmentation for successful implant placement, while using minimally invasive 
techniques. A long term evaluation with prospective randomized controlled 
clinical trials with a greater sample size and histomorphometric analysis would 
lend more credibility to this study by scientific evidences. 
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